KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to 0.56.

  • Boston Scientific's Equity Ratio rose 32.65% to 0.56 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.56, marking a year-over-year increase of 32.65%. This contributed to the annual value of 0.56 for FY2025, which is 32.65% up from last year.
  • Per Boston Scientific's latest filing, its Equity Ratio stood at 0.56 for Q4 2025, which was up 32.65% from 0.55 recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Equity Ratio ranged from a high of 0.56 in Q3 2023 and a low of 0.51 during Q1 2021
  • Its 5-year average for Equity Ratio is 0.54, with a median of 0.55 in 2024.
  • In the last 5 years, Boston Scientific's Equity Ratio plummeted by 1952.25% in 2021 and then soared by 692.11% in 2022.
  • Over the past 5 years, Boston Scientific's Equity Ratio (Quarter) stood at 0.52 in 2021, then grew by 4.94% to 0.54 in 2022, then grew by 2.7% to 0.56 in 2023, then increased by 0.48% to 0.56 in 2024, then increased by 0.33% to 0.56 in 2025.
  • Its Equity Ratio stands at 0.56 for Q4 2025, versus 0.55 for Q3 2025 and 0.55 for Q2 2025.